GBAS Antikörper (AA 176-210)
Kurzübersicht für GBAS Antikörper (AA 176-210) (ABIN6242358)
Target
Alle GBAS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 176-210
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This GBAS antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 176-210 amino acids from the Central region of human GBAS.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Haltbarkeit
- 6 months
-
-
-
: "Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production." in: Biochemical and biophysical research communications, Vol. 483, Issue 3, pp. 911-916, (2017) (PubMed).
-
: "Mitochondrial proteins NIP-SNAP-1 and -2 are a target for the immunomodulatory activity of clarithromycin, which involves NF-κB-mediated cytokine production." in: Biochemical and biophysical research communications, Vol. 483, Issue 3, pp. 911-916, (2017) (PubMed).
-
- GBAS (Glioblastoma Amplified Sequence (GBAS))
-
Andere Bezeichnung
- GBAS
-
Molekulargewicht
- 33743
-
UniProt
- O75323
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-